These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32604093)

  • 61. Personalized nutrition for colorectal cancer.
    Wang K; Song M
    Adv Cancer Res; 2021; 151():109-136. PubMed ID: 34148612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin.
    Bianchi F; Larsen N; Tieghi TM; Adorno MAT; Saad SMI; Jespersen L; Sivieri K
    Food Res Int; 2019 Jun; 120():595-602. PubMed ID: 31000276
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The microbiome and its potential as a cancer preventive intervention.
    Bultman SJ
    Semin Oncol; 2016 Feb; 43(1):97-106. PubMed ID: 26970128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.
    Cho M; Carter J; Harari S; Pei Z
    Clin Lab Med; 2014 Dec; 34(4):699-710. PubMed ID: 25439270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
    Viljoen KS; Dakshinamurthy A; Goldberg P; Blackburn JM
    PLoS One; 2015; 10(3):e0119462. PubMed ID: 25751261
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models.
    Dong J; Li Y; Xiao H; Zhang S; Wang B; Wang H; Li Y; Fan S; Cui M
    Cell Rep; 2021 Oct; 37(4):109886. PubMed ID: 34706245
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer.
    Shuwen H; Xi Y; Quan Q; Yuefen P; Miao D; Qing Z
    Future Oncol; 2019 May; 15(14):1655-1666. PubMed ID: 31044617
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
    Lawrence GW; Begley M; Cotter PD; Guinane CM
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
    Wang WY; Zhou H; Wang Z; Zhang YH
    Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer.
    Gao Z; Guo B; Gao R; Zhu Q; Wu W; Qin H
    Mol Med Rep; 2015 Oct; 12(4):6119-27. PubMed ID: 26238090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microbiome, inflammation and colorectal cancer.
    Chen J; Pitmon E; Wang K
    Semin Immunol; 2017 Aug; 32():43-53. PubMed ID: 28982615
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Intestinal Microbiota in Colorectal Cancer.
    Tilg H; Adolph TE; Gerner RR; Moschen AR
    Cancer Cell; 2018 Jun; 33(6):954-964. PubMed ID: 29657127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Relationships between the enrichment of ETBF, Fn, Hp in intestinal and colorectal cancer].
    Zhang J; Lu XL; Zhao G; Shi HT; Geng Y; Zhong WT; Dong L
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):99-104. PubMed ID: 29502368
    [No Abstract]   [Full Text] [Related]  

  • 78. Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.
    Mandal P
    Anaerobe; 2018 Feb; 49():63-70. PubMed ID: 29277623
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut microbiota profile in healthy Indonesians.
    Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
    World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
    Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
    Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.